← All trials
NCT03577262
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 23, 2018
- Primary completion
- Feb 20, 2019
- Completion date
- Mar 20, 2019
- First posted
- —
- Last posted
- —
- Enrollment
- 20
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Rodin TherapeuticsLead sponsor
- QPSCollaborator
- Free University of AmsterdamCollaborator
- University of GroningenOverall official - principal investigator
- University of GroningenCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.